Literature DB >> 10828754

Neurogenic factors and hypertension in renal disease.

V M Campese1.   

Abstract

Hypertension in chronic renal failure (CRF) is very common and contributes to morbidity and mortality and to the progression of renal disease. The pathogenesis of hypertension in CRF has been attributed mostly to sodium retention and to activation of the renin-angiotensin-aldosterone system. More recently an abundance of evidence has accumulated to support a role for increased sympathetic nervous system (SNS) activity in the genesis of hypertension associated with CRF. Evidence from our laboratory has also demonstrated that the rise in central SNS activity is mitigated by increased local expression of nitric oxide synthase (NOS)-mRNA and nitric oxide (NO) production, and that the upregulation of NO production in the brain is mediated by IL-1beta.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828754

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  19 in total

Review 1.  Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Authors:  Markus P Schlaich; Henry Krum; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

Review 2.  New therapeutic approaches to resistant hypertension.

Authors:  Markus P Schlaich; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 3.  Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure.

Authors:  Alicia A McDonough
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-01-27       Impact factor: 3.619

4.  Renal sympathetic denervation in resistant hypertension.

Authors:  Mário Santos; Henrique Carvalho
Journal:  World J Cardiol       Date:  2013-04-26

5.  CrossTalk opposing view: Which technique for controlling resistant hypertension? Renal nerve ablation.

Authors:  Markus P Schlaich; Yusuke Sata; Murray D Esler
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

6.  Comparison of high-fat style diet-induced dysregulation of baroreflex control of renal sympathetic nerve activity in intact and ovariectomized female rats: Renal sympathetic nerve activity in high-fat style diet fed intact and ovariectomized female rats.

Authors:  Yamuna Sucedaram; Edward James Johns; Ruby Husain; Munavvar Abdul Sattar; Mohammed Abdulla; Manizheh Khalilpourfarshbafi; Nor Azizan Abdullah
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-25

Review 7.  Renal denervation in human hypertension: mechanisms, current findings, and future prospects.

Authors:  Markus P Schlaich; Dagmara Hering; Paul A Sobotka; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

8.  Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure.

Authors:  Kerstin Amann; Jürgen Hofstetter; Valentina Câmpean; Andreas Koch; Marie-Luise Gross; Roland Veelken; Eberhard Ritz
Journal:  Virchows Arch       Date:  2006-05-12       Impact factor: 4.064

9.  Regulation of renal sympathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.

Authors:  Henning Hoch; Johannes Stegbauer; Sebastian A Potthoff; Lutz Hein; Ivo Quack; Lars Christian Rump; Oliver Vonend
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

10.  Regional expression of NAD(P)H oxidase and superoxide dismutase in the brain of rats with neurogenic hypertension.

Authors:  Yongli Bai; Bahman Jabbari; Shaohua Ye; Vito M Campese; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2008-11-27       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.